Following the observation that mitochondrial 1C metabolism inhibition results in proliferation arrest in CML cells, we sought to evaluate the reversibility of the cytosolic 1C pathway in CML SHMT2 KO cells. This evidence concerns the gene SHMT2 and chronic myelogenous leukemia, BCR-ABL1 positive.